Fungal complications of transplantation: diagnosis, treatment and prevention

Area of Science:

• Medical Mycology
• Transplant Infectious Diseases

Background:

• Invasive fungal infections (IFIs) pose a major threat to transplant recipients.
• Candida and Aspergillus species are the most frequent causative agents of IFIs.
• Emerging fungal pathogens like Fusarium and Trichosporon are increasingly reported in neutropenic bone marrow transplant recipients.

Purpose of the Study:

• To describe the clinical manifestations of IFIs in transplant recipients.
• To discuss diagnostic methods for IFIs in this population.
• To review treatment and prevention strategies for IFIs.

Main Methods:

• Review of clinical manifestations of IFIs.
• Discussion of diagnostic challenges and approaches.
• Analysis of therapeutic options, including empirical treatment.

Main Results:

• Diagnosis of IFIs in transplant recipients is often challenging.
• Empirical treatment with amphotericin B is associated with improved survival rates.
• Lipid-associated amphotericin B and triazoles (itraconazole, fluconazole) play key roles in management.

Conclusions:

• IFIs are a critical concern in transplant recipients, requiring prompt recognition and management.
• Timely empirical antifungal therapy, particularly with amphotericin B, is crucial for improving patient outcomes.
• Advanced antifungal agents offer effective options for treatment and prophylaxis.